Fluselenamyl: A novel benzoselenazole derivative for PET detection if amyloid plaques (Aβ) in Alzheimer's disease

Authors

G.S. M. Sundaram, Washington University School of Medicine in St. Louis
Dhruva D. Dhavale, Washington University School of Medicine in St. Louis
Julie L. Prior, Washington University School of Medicine in St. Louis
Ping Yan, Washington University School of Medicine in St. Louis
John Cirrito, Washington University School of Medicine in St. Louis
Nigam P. Rath, University of Missouri-St. Louis
Richard Laforest, Washington University School of Medicine in St. Louis
Nigel J. Cairns, Washington University School of Medicine in St. Louis
Jin-Moo Lee, Washington University School of Medicine in St. Louis
Paul T. Kotzbauer, Washington University School of Medicine in St. Louis
Vijay Sharma, Washington University School of Medicine in St. Louis

Journal

Scientific Reports

Publication Date

2016

Volume

6

Inclusive Pages

35636

Document Type

Open Access Publication

DOI

10.1038/srep35636

Rights and Permissions

G.S.M. Sundaram, et al. 02 November 2016. Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer’s Disease. Scientific reports. Art. No. 35636. DOI: 10.1038/srep35636. http://www.nature.com/articles/srep35636

Recommended Citation

Sundaram, G.S. M.; Dhavale, Dhruva D.; Prior, Julie L.; Yan, Ping; Cirrito, John; Rath, Nigam P.; Laforest, Richard; Cairns, Nigel J.; Lee, Jin-Moo; Kotzbauer, Paul T.; and Sharma, Vijay, "Fluselenamyl: A novel benzoselenazole derivative for PET detection if amyloid plaques (Aβ) in Alzheimer's disease." Scientific Reports. 6, 35636. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5392